Monitoring soluble interleukin-2 receptor levels in related and unrelated donor allogeneic bone marrow transplantation

Bone Marrow Transplantation

Volumn 21, Issue 8, 1998, Pages 769-773

  Foley, R ^a   Couban, S ^a   Walker, I ^b   Greene, K ^b   Chen, C S ^a   Messner, H ^a   Gauldie, J ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b PRINCESS MARGARET HOSPITAL   (Canada)

Author keywords

Bone marrow transplantation; Graft versus host disease; Soluble interleukin 2 receptor

Indexed keywords

INTERLEUKIN 2 RECEPTOR;

ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GRAFT VERSUS HOST REACTION; HUMAN; PRIORITY JOURNAL; SEPSIS; VEIN OCCLUSION;

EID: 0031920997     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1701163     Document Type: Article

References (22)

1. Ferrara JM, Deeg HJ. Graft-versus-host disease. New Engl J Med 1991; 324: 667-674.
2. Gale RP, Bertin MM, van Bekkum et al. Risk factors for acute graft-versus-host disease. Br J Haematol 1988; 67: 397-406.
3. Beatty PG, Hansen JA, Longton GM et al. Marrow transplantation from HLA-matched unrelated donors for treatment of hematological malignancies. Transplantation 1991; 51: 443-447.
4. Glucksberg H, Storb R, Fefer A et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HLA-matched sibling donors. Transplantation 1974; 18: 295-304.
5. Vogelsang GB, Hess AD. Graft-versus-host disease: new directions for a persistent problem. Blood 1994; 84: 2061-2067.
6. Gullen FJ, Ferrara J, Hancock WW et al. Acute cutaneous graft-versus host disease to minor histocompatibility antigens in a murine model: evidence that large granular lymphocytes are effector cells in the immune response. Lab Invest 1986; 55: 35-42.
7. Ghayur T, Seemayer TA, Lapp WS. Kinetics of natural killer cell cytotoxicity during graft-versus-host reaction. Relationship between natural killer cell activity, T and B cell activity, and development of histopathological alterations. Transplantation 1987; 44: 254-260.
8. Smith KA. Interleukin-2: inception, impact and implications. Science 1988; 240: 1169-1176.
9. Tadatsugu T, Yasuhiro M. The IL-2/IL-2 receptor system: a current overview. Cell 1993; 73: 5-8.
10. Siegert W, Josimovic-Alasevic O, Schwerdfeger R et al. Soluble interleukin 2 receptors in patients after bone marrow transplantation. Bone Marrow Transplant 1990; 6: 97-101.
11. Theobald M, Nierle T, Bunjes D et al. Host-specific interleukin-2 secreting donor T-cell precursors as predictors of acute graft-versus-host disease in bone marrow transplantation between HLA-identical siblings. New Engl J Med 1992; 327: 1613-1617.
12. Theze J, Alzari PM, Bertoglio J. Interleukin-2 and its receptors: recent advances and new immunological functions. Immunol Today 1996; 17: 481-488.
13. Rubin LA, Nelson DL. The soluble interleukin-2 receptor: biology, function and clinical applications. Ann Intern Med 1990; 113: 619-621.
14. Cornaby AJ, Simpson MA. Van Rice et al. IL-2 production in plasma and urine, plasma IL-2R levels and urine cytology as a means of monitoring allograft recipients. Transplant Proc 1988; 20: 108-112.
15. Perkins JD, Nelson DL, Rakela J et al. Soluble interleukin-2 receptor level as an indicator of liver allograft rejection. Transplantation 1989; 47: 77-81.
16. Campen DH, Horwitz DA, Quismora FP et al. Serum levels of IL-2 receptor and activity of rheumatic disease characterized by immune activation. Arthr Rheum 1988; 31: 1358-1364.
17. Miyamoto T, Akashi K, Hayashi S et al. Serum concentration of the soluble interleukin-2 receptor for monitoring acute graft-versus-host disease. Bone Marrow Transplant 1996; 17: 185-190.
18. Jones RJ, Lee KSK, Beschorner WE et al. Veno-occlusive disease of the liver following bone marrow transplantation. Transplantation 1988; 44: 778-783.
19. Weisdorf D, Haake R, Blazar B et al. Treatment of moderate/severe acute graft-versus-host disease after allogenic bone marrow transplantation: an analysis of clinical risk features and outcome. Blood 1990; 75: 1024-1030.
20. Spear ML, Stefano JL, Fawcett P, Proujansky R. Soluble interleukin-2 receptor as a predictor of neonatal sepsis. J Pediatr 1995; 126: 982-985.
21. Moussa K, Michie H, Cree I et al. Phagocyte function and cytokine production in community acquired pneumonia. Thorax 1994; 49: 107-111.
22. Rossi SJ, Schroeder TJ, Muth KL et al. Soluble interleukin-2 receptor monitoring during bacterial and viral infections in liver transplant recipients: a comparative evaluation. Clin Transplant 1994; 8: 479-484.